If you’re invested in the future of cell line development—and you’d like to explore what that future could look like—please join us for a thought-provoking event created exclusively for GSK professionals.
As 2020 so clearly reminded us, agility is key to success in the bio/pharmaceutical industry, and that won’t change any time soon, if ever. Agility in cell line development requires adaptability, flexibility and a willingness to challenge long-held assumptions.
In this live event, you’ll learn about some of the latest strategies and technologies for creating flexible, efficient and scalable workflows for even the highest-throughput cell line research environments. What’s more, you’ll discover the benefits of unique technological integrations for optimizing the speed of your standard processes and the reproducibility of the data they yield.
Finally, we’ll briefly introduce you to some of our newest analytical tools that support workflow flexibility and time savings—including the Echo 525 acoustic liquid handler, Biomek i7 liquid handler, the CytoFLEX SRT benchtop cell sorter and the Vi-CELL BLU cell viability analyzer.
In many ways, the future of cell line development is already here. Join us on June 23 for a lively discussion on the impact that future will have on all of us.
Lunch is provided for GSK attendees. A link to order lunch will be included in the registration confirmation email.